Question 1

What is Shilpa Medicare — Shilpa Biologicals Private Limited?

Accepted Answer

Shilpa Medicare — Shilpa Biologicals Private Limited is a Entity.

Question 2

How often does Shilpa Medicare — Shilpa Biologicals Private Limited appear in global news?

Accepted Answer

Tracked across 1 news events drawn from 6 articles.

Question 3

When was Shilpa Medicare — Shilpa Biologicals Private Limited first tracked by Ergen?

Accepted Answer

First tracked on Jun 30, 2026.

Question 4

When was Shilpa Medicare — Shilpa Biologicals Private Limited last mentioned in news?

Accepted Answer

Last active on Jul 06, 2026.

Question 5

What is Shilpa Medicare — Shilpa Biologicals Private Limited's current news sentiment?

Accepted Answer

Aggregate sentiment score: 70 on a -100 to +100 scale (negative = critical coverage, positive = favorable coverage).

Question 6

How prominent is Shilpa Medicare — Shilpa Biologicals Private Limited in global news coverage?

Accepted Answer

Attention score of 4, derived from article volume and coverage intensity across 1 events.

Question 7

What is the most recent event involving Shilpa Medicare — Shilpa Biologicals Private Limited?

Accepted Answer

Orion, Shilpa Medicare Nivolumab Biosimilar Europe (Jun 30, 2026, 6 articles).

Question 8

How did the "Orion, Shilpa Medicare Nivolumab Biosimilar Europe" event impact Shilpa Medicare — Shilpa Biologicals Private Limited?

Accepted Answer

Shilpa Medicare — Shilpa Biologicals Private Limited is responsible for the development and manufacture of the nivolumab biosimilar and will supply it to Orion. This agreement is a defining moment for the company, extending its partnership with Orion into immuno-oncology.

Question 9

How is this data collected?

Accepted Answer

Ergen aggregates thousands of global news sources and extracts structured events, entities, and relationships with sentiment and attention metrics. Pages are daily static snapshots from the platform's live database.